Journal of Medicinal Chemistry p. 2318 - 2325 (1989)
Update date:2022-08-05
Topics:
DeVries, Vern G.
Bloom, Jonathan D.
Dutia, Minu D.
Katocs, Andrew S.
Largis, Elwood E.
The discovery that a series of N,N-dialkyl-N'-arylureas were inhibitors of the ACAT enzyme has led to a structure-activity study involving the systematic modification of three sites of the urea backbone.This study culminated in the selection of N'-(2,4-dimethylphenyl)-N-benzyl-N-n-butylurea (115) for more extensive biological evaluation.ACAT inhibitors are seen as potentially beneficial agents against hypercholesterolemia and atherosclerosis.
View Morewebsite:http://www.lidepharma.com
Contact:+86-25-58409506
Address:Chungking Express Nos.36 Nathan Road，Kowloon, HK
MTT Pharma & Bio-technology Co.,Ltd(expird)
Contact:+86-21-58407925
Address:Room2019, Building C, Tomson Center, No.158, Zhang Yang Road, Shanghai, China
Guangzhou PI & PI Biotech Inc. Ltd.
Contact:+86-20-81716320
Address:13th Floor, Xinbao Technology Industrial Park, No. 2 Ruixiang Road, Huangpu District, Guangzhou,Guangdong,China
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
website:http://www.greenutra.cn
Contact:0086-411-39553357
Address:No. 7-1-1802, Huizhi Garden,Ocean Square,Dalian, 116033, China
Doi:10.1021/jo052569u
(2006)Doi:10.1021/ic052091c
(2006)Doi:10.1016/j.bmc.2005.11.043
(2006)Doi:10.1016/S0022-328X(00)99299-4
(1983)Doi:10.1021/ic052158w
(2006)Doi:10.1021/jo0711539
(2007)
